Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Integrating a Host-Protein Bacterial/Viral Test into the Emergency Department Sepsis Alert Order Set Is Associated with Changes in Sepsis Category Distribution and Patient Management: A Pre/Postimplementation Study.

Created on 13 Nov 2026

Authors

Marci O'Driscoll, Suzanne Silbert, Tashkin Tokaria, Shannon Young, Ashkon Chamani, Daniel Wind, Kimberly Munoz, Jason W Wilson

Published in

Critical care explorations. Volume 8. Issue 11. Pages e1523. Nov 01, 2026. Epub Nov 13, 2026.

Abstract

To evaluate the impact of implementing a host-protein bacterial/viral test in the emergency department (ED) sepsis alert order set.
Pre/postimplementation study. Host-protein testing was automatically ordered both pre- and postimplementation as part of the ED sepsis alert order set; test results were accessible to treating clinicians only postimplementation. The pre- (September 2024 to December 2024) to postimplementation (January 2025 to March 2025) transition also involved education on the host-protein test to ED clinicians. The primary outcome was patient classification into Surviving Sepsis Campaign (SSC) sepsis categories (definite/probable vs. possible vs. unlikely sepsis).
ED of an academic medical center.
Adults who triggered the ED sepsis alert order set.
Host-protein bacterial/viral test (MeMed BV) automatically ordered in ED sepsis alert order set. Test result was only visible to clinicians postimplementation.
There were 893 eligible patients; 505 patients in the preimplementation cohort and 388 in the postimplementation cohort. The distribution of SSC sepsis categories differed between pre- and postimplementation cohorts (χ2(2) = 8.73; p = 0.013). The difference was primarily driven by a larger proportion of patients classified as unlikely sepsis (from 32.5% to 41.1%; p = 0.009) and a smaller proportion classified as possible sepsis (from 18.4% to 13.2%; p = 0.043). Among unlikely sepsis patients, host-protein test implementation was associated with ordering fewer cefepime doses (from 3.3 to 2.2; p = 0.044) and a lower hospitalization rate (from 92.1% to 79.9%; p = 0.002).
These findings support an association between host-protein testing for patients triggering ED sepsis alerts and the distribution of possible vs. unlikely sepsis cases. Multicenter clinical utility studies are warranted.

PMID:
43023823
Bibliographic data and abstract were imported from PubMed on 13 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 8
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement